Skip to main content

Advertisement

Log in

Synovial fluid level of adiponectin correlated with levels of aggrecan degradation markers in osteoarthritis

  • Original Article
  • Published:
Rheumatology International Aims and scope Submit manuscript

Abstract

The objective of this study was to investigate adiponectin levels in both plasma and synovial fluid of female patients with knee osteoarthritis (OA) and to analyze the correlation between adiponectin and degradation markers of cartilage matrix in synovial fluid. Thirty female patients with knee OA were enrolled in this study. Levels of adiponectin and degradation markers of cartilage matrix were measured using enzyme-linked immunosorbent assay. Adiponectin level in synovial fluid was significantly lower with respect to paired plasma level (0.93 ± 0.64 vs. 7.50 ± 3.29 μg/ml, P < 0.001). Correlation analysis showed that synovial fluid adiponectin significantly correlated with degradation markers of aggrecan, AGG1 (r = 0.441, P = 0.015) and AGG2 (r = 0.445, P = 0.014), but not significantly correlated with degradation marker of collagen II, CTX-II. These findings suggest that adiponectin might involve in the regulation of the degradation of cartilage matrix in OA.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Hochberg MC, Altman RD, Brandt KD, Clark BM, Dieppe PA, Griffin MR et al (1995) Guidelines for the medical management of osteoarthritis. Part I. Osteoarthritis of the hip. American College of Rheumatology. Arthritis Rheum 38(11):1535–1540

    Article  PubMed  CAS  Google Scholar 

  2. Oliveria SA, Felson DT, Cirillo PA, Reed JI, Walker AM (1999) Body weight, body mass index, and incident symptomatic osteoarthritis of the hand, hip, and knee. Epidemiology 10(2):161–166

    Article  PubMed  CAS  Google Scholar 

  3. Cicuttini FM, Baker JR, Spector TD (1996) The association of obesity with osteoarthritis of the hand and knee in women: a twin study. J Rheumatol 23(7):1221–1226

    PubMed  CAS  Google Scholar 

  4. Toda Y, Toda T, Takemura S, Wada T, Morimoto T, Ogawa R (1998) Change in body fat, but not body weight or metabolic correlates of obesity, is related to symptomatic relief of obese patients with knee osteoarthritis after a weight control program. J Rheumatol 25(11):2181–2186

    PubMed  CAS  Google Scholar 

  5. Kershaw EE, Flier JS (2004) Adipose tissue as an endocrine organ. J Clin Endocrinol Metab 89(6):2548–2556

    Article  PubMed  CAS  Google Scholar 

  6. Pottie P, Presle N, Terlain B, Netter P, Mainard D, Berenbaum F (2006) Obesity and osteoarthritis: more complex than predicted!. Ann Rheum Dis 65(11):1403–1405

    Article  PubMed  CAS  Google Scholar 

  7. Nowell MA, Richards PJ, Fielding CA, Ognjanovic S, Topley N, Williams AS et al (2006) Regulation of pre-B cell colony-enhancing factor by STAT-3-dependent interleukin-6 trans-signaling implications in the pathogenesis of rheumatoid arthritis. Arthritis Rheum 54(7):2084–2095

    Article  PubMed  CAS  Google Scholar 

  8. Presle N, Pottie P, Dumond H, Guillaume C, Lapicque F, Pallu S et al (2006) Differential distribution of adipokines between plasma and synovial fluid in patients with osteoarthritis. Contribution of joint tissues to their articular production. Osteoarthr Cartil 14(7):690–695

    Article  PubMed  CAS  Google Scholar 

  9. Schäffler A, Ehling A, Neumann E, Herfarth H, Tarner I, Schölmerich J et al (2003) Adipocytokines in synovial fluid. JAMA 290(13):1709–1710

    Article  PubMed  Google Scholar 

  10. Chen TH, Chen L, Hsieh MS, Chang CP, Chou DT, Tsai SH (2006) Evidence for a protective role for adiponectin in osteoarthritis. Biochim Biophys Acta 1762(8):711–718

    PubMed  CAS  Google Scholar 

  11. Ehling A, Schäffler A, Herfarth H, Tarner IH, Anders S, Distler O et al (2006) The potential of adiponectin in driving arthritis. J Immunol 176(7):4468–4478

    PubMed  CAS  Google Scholar 

  12. Lago R, Gomez R, Otero M, Lago F, Gallego R, Dieguez C et al (2008) A new player in cartilage homeostasis: adiponectin induces nitric oxide synthase type II and pro-inflammatory cytokines in chondrocytes. Osteoarthr Cartil 16(9):1101–1109

    Article  PubMed  CAS  Google Scholar 

  13. Altman R, Asch E, Bloch D, Bole G, Borenstein D, Brandt K et al (1986) Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and therapeutic criteria committee of the American Rheumatism Association. Arthritis Rheum 29(8):1039–1049

    Article  PubMed  CAS  Google Scholar 

  14. Li M, Fisette A, Zhao XY, Deng JY, Mi J, Cianflone K (2009) Serum resistin correlates with central obesity but weakly with insulin resistance in Chinese children and adolescents. Int J Obes 33(4):424–439

    Article  Google Scholar 

  15. Arner EC (2002) Aggrecanase-mediated cartilage degradation. Curr Opin Pharmacol 2(3):322–329

    Article  PubMed  CAS  Google Scholar 

  16. Sztrolovics R, Alini M, Roughley PJ, Mort JS (1997) Aggrecan degradation in human intervertebral disc and articular cartilage. J Biochem 326(1):235–241

    CAS  Google Scholar 

  17. Martel-Pelletier J, Boileau C, Pelletier JP, Roughley PJ (2008) Cartilage in normal and osteoarthritis conditions. Best Pract Res Clin Rheum 22(2):351–384

    Article  CAS  Google Scholar 

  18. Fosang AJ, Neame PJ, Last K, Hardingham TE, Murphy G, Hamilton JA (1992) The interglobular domain of cartilage aggrecan is cleaved by PUMP, gelatinases, and cathepsin B. J Biol Chem 267(27):19470–19474

    PubMed  CAS  Google Scholar 

  19. Ouchi N, Kihara S, Funahashi T, Matsuzawa Y, Walsh K (2003) Obesity, adiponectin and vascular inflammatory disease. Curr Opin Lipidol 14(6):561–566

    Article  PubMed  CAS  Google Scholar 

  20. Kobayashi H, Ouchi N, Kihara S, Walsh K, Kumada M, Abe Y et al (2004) Selective suppression of endothelial cell apoptosis by the high molecular weight form of adiponectin. Circ Res 94(4):e27–e31

    Article  PubMed  CAS  Google Scholar 

  21. Pajvani UB, Hawkins M, Combs TP, Rajala MW, Doebber T, Berger JP et al (2004) Complex distribution, not absolute amount of adiponectin, correlates with thiazolidinedione-mediated improvement in insulin sensitivity. J Biol Chem 279(13):12152–12162

    Article  PubMed  CAS  Google Scholar 

  22. Rubenstein JH, Kao JY, Madanick RD, Zhang M, Wang M, Spacek MB et al (2009) Association of adiponectin multimers with Barrett’s esophagus. Gut 58(12):1583–1589

    Article  PubMed  CAS  Google Scholar 

  23. Hug C, Wang J, Ahmad NS, Bogan JS, Tsao TS, Lodish HF et al (2004) T-cadherin is a receptor for hexameric and high-molecular-weight forms of Acrp30/adiponectin. Proc Natl Acad Sci 101(28):10308–10313

    Article  PubMed  CAS  Google Scholar 

  24. Yamauchi T, Kamon J, Ito Y, Tsuchida A, Yokomizo T, Kita S et al (2003) Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature 423(6941):762–769

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

The authors would like to thank Dr. Jin Jin, Jin Lin, and Xisheng Wen for their help in sample collections and Linxin Xu for technical assistance.

Conflict of interest statement

The authors declare that they have no conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Guixing Qiu.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hao, D., Li, M., Wu, Z. et al. Synovial fluid level of adiponectin correlated with levels of aggrecan degradation markers in osteoarthritis. Rheumatol Int 31, 1433–1437 (2011). https://doi.org/10.1007/s00296-010-1516-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00296-010-1516-0

Keywords

Navigation